Partnerships, Licensing, Investments and M&A Deals and Trends for July 2019 in Pharmaceuticals

GlobalData
84 Pages - GLDATA68602
$1,000.00

Summary

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for July 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in July 2019.

The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

'

Table of Contents
1.1 List of Tables 5
1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary 10
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, July 2019 10
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, July 2019 12
2.2.1 Gilead Sciences and Galapagos to Enter into R&D Agreement 12
2.2.2 Merck Raises USD909.31 Million in Private Placement of Bonds 13
2.2.3 Genentech Enters into Licensing Agreement with Skyhawk Therapeutics 13
2.2.4 Boehringer Ingelheim Enters into Licensing Agreement with Bridge Biotherapeutics 14
2.2.5 Genentech Enters into Licensing Agreement with Sosei Heptares 14
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, July 2019 15
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, July 2019 16
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 17
3.1 Pharmaceuticals & Healthcare, Global, M&A, July 2019 17
3.1.1 Top M&A Deals in July 2019 18
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, February 2019 - July 2019 19
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, July 2019 20
3.2.1 Top Equity Offering Deals in July 2019 21
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, February 2019 - July 2019 22
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, July 2019 23
3.3.1 Top PE/VC Deals in July 2019 24
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, July 2019 25
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, July 2019 26
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2016-July 2019 28
3.3.7 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2016-July 2019 29
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, July 2019 30
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, February 2019 - July 2019 31
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), July 2019 32
3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, July 2019 33
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 34
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, February 2019 - July 2019 35
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), February 2019 - July 2019 36
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 37
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, July 2019 38
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, July 2019 38
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2019 39
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), February 2019 - July 2019 40
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), February 2019 - July 2019 41
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), February 2019 - July 2019 42
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), February 2019 - July 2019 44
4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, July 2019 45
4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, July 2019 45
4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, July 2019 46
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 47
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, July 2019 47
5.1.1 Oncology - Deals of the Month 48
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, July 2019 51
5.2.1 Central Nervous System - Deals of the Month 52
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, July 2019 54
5.3.1 Infectious Diseases - Deals of the Month 55
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, July 2019 58
5.4.1 Cardiovascular - Deals of the Month 59
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, July 2019 60
5.5.1 Immunology - Deal of the Month 61
5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, July 2019 63
5.6.1 Gastrointestinal - Deals of the Month 64
5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, July 2019 66
5.7.1 Metabolic Disorders - Deals of the Month 67
6 Deal Summary by Geography 69
6.1 Pharmaceuticals & Healthcare, North America Deals, July 2019 69
6.1.1 North America - Deals of the Month 70
6.2 Pharmaceuticals & Healthcare, Europe, Deals, July 2019 72
6.2.1 Europe - Deals of the Month 73
6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, July 2019 74
6.3.1 Asia-Pacific - Deals of the Month 75
6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, July 2019 77
6.4.1 Rest of the World - Deals of the Month 78
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 80
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, February 2019 - July 2019 80
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, February 2019 - July 2019 81
8 Further Information 82
8.1 Methodology 82
8.2 About GlobalData 83
8.3 Contact Us 83
8.4 Disclosure information 83
8.5 Disclaimer 84

List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 11
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, July 2019 12
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), July 2019 16
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 18
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, July 2019 18
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, February 2019 - July 2019 19
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 21
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, July 2019 21
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 22
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 24
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, July 2019 24
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, February 2019 - July 2019 25
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), July 2019 27
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 28
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, February 2019 - July 2019 29
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 30
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 31
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 32
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), July 2019 33
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 34
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, February 2019 - July 2019 36
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), February 2019 - July 2019 37
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 38
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 39
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 40
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), July 2019 41
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, February 2019 - July 2019 43
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2019 44
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, July 2019 45
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, July 2019 45
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, July 2019 46
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 48
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 52
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 55
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 59
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 61
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 64
Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 67
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 70
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 73
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 75
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 78
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 80
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 81

List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 10
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), July 2019 15
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), July 2019 16
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 17
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, February 2019 - July 2019 19
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 20
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 22
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 23
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, February 2019 - July 2019 25
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), July 2019 26
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), July 2019 27
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 28
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 30
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 31
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 32
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 34
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, February 2019 - July 2019 35
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, February 2019 - July 2019 36
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 37
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 38
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 39
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 40
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), February 2019 - July 2019 41
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, February 2019 - July 2019 42
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), February 2019 - July 2019 43
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), July 2019 44
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 47
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 51
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 54
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 58
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 60
Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 63
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 66
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 69
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 72
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 74
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 77
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 80
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), February 2019 - July 2019 81

$1,000.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports